Treatment of menkes disease with parenteral copper histidine

Indian Pediatrics

Volumn 39, Issue 2, 2002, Pages 183-185

  Kirodian, B C ^a   Gogtay, N J ^a   Udani, V P ^b   Kshirsagar, N A ^a  

^a KEM HOSPITAL   (India)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER DERIVATIVE; HISTIDINE COPPER; HISTIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; CLINICAL FEATURE; CONSANGUINEOUS MARRIAGE; COPPER BLOOD LEVEL; FOLLOW UP; HUMAN; INFANT; MENKES SYNDROME; TREATMENT OUTCOME;

FOLLOW-UP STUDIES; HISTIDINE; HUMANS; INDIA; INFANT; INJECTIONS, SUBCUTANEOUS; MALE; MENKES KINKY HAIR SYNDROME; ORGANOMETALLIC COMPOUNDS; TREATMENT OUTCOME;

EID: 0036182229     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Kodama H, Murata Y, Kobayashi M. Clinical manifestations and treatment of Menkes disease and its variants. Pediatr Int 1999; 41: 423-429.
2. 67Copper uptake. J Inorg Biochem 1990; 40: 81-93.
3. Kaler SG. Menkes disease. Adv Pediatr 1994; 41: 263-304.
4. Sarkar B, Walsh K, Clark TR. Copper histidine therapy for Menkes disease. J Pediatr 1993; 123: 828-830.
5. Tanaka K, Kobayashi K, Fujita Y, Fukuhara C, Onosaka S, Min K. Effects of chelators on copper therapy of macular mouse: A model animal of Menkes' kinky disease. Res Commun Chem Pathol Pharmacol 1990; 69: 217-227.